Human medicines European public assessment report (EPAR): Zessly, infliximab, Date of authorisation: 18/05/2018, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Zessly, infliximab, Date of authorisation: 18/05/2018, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Zessly, infliximab, Date of authorisation: 18/05/2018, Revision: 15, Status: Authorised
